Division of Nephrology, Department of Internal Medicine, China Medical University Hospital, Taiwan.
Perit Dial Int. 2011 Sep-Oct;31(5):551-7. doi: 10.3747/pdi.2009.00171. Epub 2010 Jun 30.
Nephrologists commonly recommend continuous ambulatory peritoneal dialysis (CAPD) with break-in periods of at least 2 weeks. We investigated the safety and feasibility of shorter break-in periods following surgical implantation of Tenckhoff catheters.
We retrospectively examined 310 patients that underwent Tenckhoff catheter implantation for the first time. The early group comprised 226 patients that started CAPD ≤ 14 days after implantation; the late group comprised 84 patients that started CAPD > 14 days after implantation. Catheter-related complications within 6 months were analyzed.
A total of 310 patients were enrolled. Time to CAPD initiation was shorter in the early group (2.0 ± 2.7 days) than in the late group (40.6 ± 42.8 days) (p < 0.001). The bridge hemodialysis rate was higher in the late group (57.1%) than in the early group (31.4%) (p < 0.001). Overall, 33 early-group (14.6%) and 11 late-group patients (13.1%) developed catheter-related complications within 6 months. The early-group complications were leakage (n = 5), diminished outflow volume (n = 7), migration (n = 7), pericatheter hernia (n = 1), hemoperitoneum (n = 1), pericatheter infection (n = 3), and peritonitis (n = 9). The late-group complications were leakage (n = 2), diminished outflow volume (n = 5), migration (n = 2), and peritonitis (n = 2). Actuarial freedom from catheter-related complications was similar in both groups (log rank, p = 0.76).
Early initiation of CAPD with surgically implanted Tenckhoff catheters is feasible and safe. Shorter break-in periods are not associated with more catheter-related complications. The data from our peritoneal dialysis population suggest that early initiation is not associated with an increased number of complications. This needs to be confirmed in a randomized trial.
肾病专家通常建议使用持续非卧床腹膜透析(CAPD),并在植入 Tenckhoff 导管后至少进行 2 周的适应期。我们研究了在手术后植入 Tenckhoff 导管后较短的适应期的安全性和可行性。
我们回顾性地检查了首次接受 Tenckhoff 导管植入的 310 例患者。早期组包括 226 例患者,他们在植入后 ≤ 14 天开始 CAPD;晚期组包括 84 例患者,他们在植入后 > 14 天开始 CAPD。在 6 个月内分析导管相关并发症。
共纳入 310 例患者。早期组(2.0 ± 2.7 天)开始 CAPD 的时间短于晚期组(40.6 ± 42.8 天)(p < 0.001)。晚期组桥接血液透析率(57.1%)高于早期组(31.4%)(p < 0.001)。总体而言,33 例早期组(14.6%)和 11 例晚期组患者(13.1%)在 6 个月内发生了导管相关并发症。早期组并发症包括渗漏(n = 5)、流出量减少(n = 7)、迁移(n = 7)、导管周围疝(n = 1)、血腹(n = 1)、导管周围感染(n = 3)和腹膜炎(n = 9)。晚期组并发症包括渗漏(n = 2)、流出量减少(n = 5)、迁移(n = 2)和腹膜炎(n = 2)。两组的导管相关并发症无差异(对数秩检验,p = 0.76)。
早期开始使用植入的 Tenckhoff 导管进行 CAPD 是可行和安全的。较短的适应期与更多的导管相关并发症无关。我们腹膜透析患者的数据表明,早期开始不会导致并发症数量增加。这需要在随机试验中得到证实。